Affinity DataIC50: 1.40nMAssay Description:Antagonist activity at CRTh2 receptor in human eosinophil assessed as inhibition of PGD2-induced cell shape changeMore data for this Ligand-Target Pair
Affinity DataIC50: 8nMAssay Description:Antagonist activity at CRTh2 receptor in human eosinophil assessed as inhibition of PGD2-induced cell shape changeMore data for this Ligand-Target Pair
Affinity DataIC50: 9nMAssay Description:Antagonist activity at CRTh2 receptor (unknown origin) overexpressed in CHOK1 cell membranes assessed as inhibition of [35S]-GTPgammaS binding at 1 t...More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Antagonist activity at CRTh2 receptor (unknown origin) overexpressed in CHOK1 cell membranes assessed as inhibition of [35S]-GTPgammaS binding at 1 t...More data for this Ligand-Target Pair
Affinity DataIC50: 13nMAssay Description:Antagonist activity at CRTh2 receptor in human eosinophil assessed as inhibition of PGD2-induced cell shape changeMore data for this Ligand-Target Pair
Affinity DataIC50: 14nMAssay Description:Antagonist activity at CRTh2 receptor in human eosinophil assessed as inhibition of PGD2-induced cell shape changeMore data for this Ligand-Target Pair
Affinity DataIC50: 15nMAssay Description:Antagonist activity at CRTh2 receptor (unknown origin) overexpressed in CHOK1 cell membranes assessed as inhibition of [35S]-GTPgammaS binding at 1 t...More data for this Ligand-Target Pair
Affinity DataIC50: 16nMAssay Description:Antagonist activity at CRTh2 receptor (unknown origin) overexpressed in CHOK1 cell membranes assessed as inhibition of [35S]-GTPgammaS binding at 1 t...More data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:Antagonist activity at CRTh2 receptor in human eosinophil assessed as inhibition of PGD2-induced cell shape changeMore data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:Antagonist activity at CRTh2 receptor (unknown origin) overexpressed in CHOK1 cell membranes assessed as inhibition of [35S]-GTPgammaS binding at 1 t...More data for this Ligand-Target Pair
Affinity DataIC50: 19nMAssay Description:Antagonist activity at CRTh2 receptor (unknown origin) overexpressed in CHOK1 cell membranes assessed as inhibition of [35S]-GTPgammaS binding at 1 t...More data for this Ligand-Target Pair
Affinity DataIC50: 20nMAssay Description:Antagonist activity at CRTh2 receptor in human eosinophil assessed as inhibition of PGD2-induced cell shape changeMore data for this Ligand-Target Pair
Affinity DataIC50: 32nMAssay Description:Antagonist activity at CRTh2 receptor (unknown origin) overexpressed in CHOK1 cell membranes assessed as inhibition of [35S]-GTPgammaS binding at 1 t...More data for this Ligand-Target Pair
Affinity DataIC50: 37nMAssay Description:Antagonist activity at CRTh2 receptor (unknown origin) overexpressed in CHOK1 cell membranes assessed as inhibition of [35S]-GTPgammaS binding at 1 t...More data for this Ligand-Target Pair
Affinity DataIC50: 43nMAssay Description:Antagonist activity at CRTh2 receptor (unknown origin) overexpressed in CHOK1 cell membranes assessed as inhibition of [35S]-GTPgammaS binding at 1 t...More data for this Ligand-Target Pair
Affinity DataIC50: 43nMAssay Description:Antagonist activity at CRTh2 receptor in human eosinophil assessed as inhibition of PGD2-induced cell shape changeMore data for this Ligand-Target Pair
Affinity DataIC50: 47nMAssay Description:Antagonist activity at CRTh2 receptor in human eosinophil assessed as inhibition of PGD2-induced cell shape changeMore data for this Ligand-Target Pair
Affinity DataIC50: 48nMAssay Description:Antagonist activity at CRTh2 receptor (unknown origin) overexpressed in CHOK1 cell membranes assessed as inhibition of [35S]-GTPgammaS binding at 1 t...More data for this Ligand-Target Pair
Affinity DataIC50: 48nMAssay Description:Antagonist activity at CRTh2 receptor (unknown origin) overexpressed in CHOK1 cell membranes assessed as inhibition of [35S]-GTPgammaS binding at 1 t...More data for this Ligand-Target Pair
Affinity DataIC50: 58nMAssay Description:Antagonist activity at CRTh2 receptor in human eosinophil assessed as inhibition of PGD2-induced cell shape changeMore data for this Ligand-Target Pair
Affinity DataIC50: 63nMAssay Description:Antagonist activity at CRTh2 receptor in human eosinophil assessed as inhibition of PGD2-induced cell shape changeMore data for this Ligand-Target Pair
Affinity DataIC50: 82nMAssay Description:Antagonist activity at CRTh2 receptor (unknown origin) overexpressed in CHOK1 cell membranes assessed as inhibition of [35S]-GTPgammaS binding at 1 t...More data for this Ligand-Target Pair
Affinity DataIC50: 84nMAssay Description:Antagonist activity at CRTh2 receptor in human eosinophil assessed as inhibition of PGD2-induced cell shape changeMore data for this Ligand-Target Pair
Affinity DataIC50: 94nMAssay Description:Antagonist activity at CRTh2 receptor in human eosinophil assessed as inhibition of PGD2-induced cell shape changeMore data for this Ligand-Target Pair
Affinity DataIC50: 123nMAssay Description:Antagonist activity at CRTh2 receptor (unknown origin) overexpressed in CHOK1 cell membranes assessed as inhibition of [35S]-GTPgammaS binding at 1 t...More data for this Ligand-Target Pair
Affinity DataIC50: 159nMAssay Description:Antagonist activity at CRTh2 receptor (unknown origin) overexpressed in CHOK1 cell membranes assessed as inhibition of [35S]-GTPgammaS binding at 1 t...More data for this Ligand-Target Pair
Affinity DataIC50: 247nMAssay Description:Antagonist activity at CRTh2 receptor (unknown origin) overexpressed in CHOK1 cell membranes assessed as inhibition of [35S]-GTPgammaS binding at 1 t...More data for this Ligand-Target Pair
Affinity DataIC50: 262nMAssay Description:Antagonist activity at CRTh2 receptor (unknown origin) overexpressed in CHOK1 cell membranes assessed as inhibition of [35S]-GTPgammaS binding at 1 t...More data for this Ligand-Target Pair
Affinity DataIC50: 398nMAssay Description:Antagonist activity at CRTh2 receptor (unknown origin) overexpressed in CHOK1 cell membranes assessed as inhibition of [35S]-GTPgammaS binding at 1 t...More data for this Ligand-Target Pair